lymphoproliferative disorder
Showing 26 - 48 of 48
Methemoglobinemia in Young Hematologic Cancer or Aplastic Anemia
Completed
- Chronic Myeloproliferative Disorders
- +8 more
- chemotherapy
- +3 more
-
Nashville, Tennessee
- +1 more
Apr 13, 2017
Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in United States (biological, drug, other, procedure)
Terminated
- Leukemia
- +5 more
- anti-thymocyte globulin
- +11 more
-
Lewes, Delaware
- +9 more
Feb 6, 2017
Anemia, Leukemia, Lymphoma Trial in Rochester (darbepoetin alfa, epoetin alfa, fatigue assessment and management)
Completed
- Anemia
- +6 more
- darbepoetin alfa
- +3 more
-
Rochester, MinnesotaMayo Clinic
Dec 19, 2016
Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in United States (American ginseng, )
Completed
- Chronic Myeloproliferative Disorders
- +9 more
- American ginseng
- placebo
-
Scottsdale, Arizona
- +325 more
Dec 19, 2016
Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)
Completed
- Cachexia
- +3 more
- Juven
- Non-Juven Supplement
-
Birmingham, Alabama
- +249 more
Dec 6, 2016
Anemia, Leukemia, Lymphoma Trial in United States (epoetin alfa)
Completed
- Anemia
- +6 more
- epoetin alfa
-
Scottsdale, Arizona
- +17 more
Jul 15, 2016
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Duarte (cytology specimen collection procedure,
Terminated
- Brain and Central Nervous System Tumors
- +9 more
- cytology specimen collection procedure
- +2 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Jun 3, 2015
Brain and CNS Tumors, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (imetelstat sodium, laboratory
Completed
- Brain and Central Nervous System Tumors
- +4 more
- imetelstat sodium
- +2 more
-
Birmingham, Alabama
- +22 more
Jan 29, 2014
Lymphoproliferative Disorder Trial in United Kingdom (therapeutic allogeneic lymphocytes)
Unknown status
- Lymphoproliferative Disorder
- therapeutic allogeneic lymphocytes
-
Birmingham, England, United Kingdom
- +11 more
Dec 18, 2013
Lung Cancer, Lymphoma, Lymphoproliferative Disorder Trial in Los Angeles (gemcitabine HCl, motesanib diphosphate,
Unknown status
- Lung Cancer
- +3 more
- gemcitabine hydrochloride
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Sep 16, 2013
Studying Fentanyl in Patients With Cancer
Terminated
- Brain and Central Nervous System Tumors
- +10 more
- fentanyl citrate
- pharmacological study
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 16, 2013
Myeloproliferative Disorders, Leukemia, Lymphoma Trial (aprepitant, ondansetron HCl)
Withdrawn
- Myeloproliferative Disorders
- +7 more
- aprepitant
- ondansetron hydrochloride
- (no location specified)
Mar 29, 2013
Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in New York (beta-glucan, rituximab)
Terminated
- Leukemia
- +2 more
- beta-glucan
- rituximab
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Mar 18, 2013
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Seoul (donor natural killer cell infusion)
Completed
- Brain and Central Nervous System Tumors
- +8 more
- donor natural killer cell infusion
-
Seoul, Korea, Republic ofUniversity of Ulsan, Asan Medical Center
Feb 18, 2013
Chronic Myeloproliferative Disorders, Infection, Leukemia Trial (Edetate Calcium Disodium, Ethanol,
Withdrawn
- Chronic Myeloproliferative Disorders
- +8 more
- Edetate Calcium Disodium
- +3 more
- (no location specified)
Feb 13, 2013
Anemia, Leukemia, Lymphoma Trial in Los Angeles (epoetin alfa)
Completed
- Anemia
- +6 more
- epoetin alfa
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Oct 3, 2012
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in United States (educational intervention, Titrated
Completed
- Brain and Central Nervous System Tumors
- +10 more
- educational intervention
- +2 more
-
Hopkinsville, Kentucky
- +10 more
Aug 4, 2012
Lung Cancer, Lymphoma, Lymphoproliferative Disorder Trial run by the CC (biological, drug, other)
Completed
- Lung Cancer
- +4 more
- bevacizumab
- +3 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 14, 2012
Quality of Life in Younger Leukemia and Lymphoma Survivors
Completed
- Anxiety Disorder
- +9 more
- telephone-based intervention
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Aug 23, 2011
Anemia, Leukemia, Lymphoma Trial in Scottsdale, Rochester (biological, dietary supplement, drug, other)
Completed
- Anemia
- +6 more
- darbepoetin alfa
- +3 more
-
Scottsdale, Arizona
- +1 more
May 13, 2011
Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer Trial in Buffalo (Src kinase inhibitor KX2-391, immunoenzyme
Completed
- Lymphoma
- +3 more
- Src kinase inhibitor KX2-391
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2011
Autoimmune Disease, Lymphoproliferative Disorder Trial run by the NIAID (Fansidar (pyrimethamine and sulfadoxine))
Completed
- Autoimmune Disease
- Lymphoproliferative Disorder
- Fansidar (pyrimethamine and sulfadoxine)
-
Bethesda, MarylandNational Institute of Allergy and Infectious Diseases (NIAID)
Mar 3, 2008
Autoimmune Disease, Lymphatic Disease, Lymphoproliferative Disorder Trial run by the NIAID (Pyrimethamine)
Completed
- Autoimmune Disease
- +2 more
-
Bethesda, MarylandNational Institute of Allergy and Infectious Diseases (NIAID)
Mar 3, 2008